Papers - Nakajima, Shinichiro

Effect of glutamatergic modulators on cognitive impairment in schizophrenia – systematic review and meta-analysis.

Iwata Y, Nakajima S** (co-first), Suzuki T, Keefe R, Plitman E, Chung J, Caravaggio F, Masaru M, Graff-Guerrero A, Uchida H.

Molecular Psychiatry.  2015

Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia.

Caravaggio F, Hahn M, Nakajima S, Gerretsen P, Remington G, Graff-Guerrero A.

Med Hypotheses.  2015

The VAGUS insight into psychosis scale--self-report and clinician-rated versions.

Gerretsen P, Remington G, Borlido C, Quilty L, Hassan S, Polsinelli G, Teo C, Mar W, Simon R, Menon M, Pothier DD, Nakajima S, Caravaggio F, Mamo DC, Rajji TK, Mulsant BH, Deluca V, Ganguli R, Pollock BG, Graff-Guerrero A.

Psychiatry Res.  2014

Psychosis in frontotemporal dementia.

Shinagawa S, Nakajima S, Plitman E, Graff-Guerrero A, Mimura M, Nakayama K, Miller BL.

J Alzheimers Dis.  2014

Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.

Caravaggio F1, Nakajima S2, Borlido C3, Remington G4, Gerretsen P, Wilson A, Houle S, Menon M, Mamo D, Graff-Guerrero A.

Neuropsychopharmacology.  2014

Glutamate-mediated excitotoxicity in schizophrenia: a review.

Plitman E1, Nakajima S2, de la Fuente-Sandoval C3, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JK, Caravaggio F, Iwata Y, Remington G, Graff-Guerrero A.

Eur Neuropsychopharmacol.  2014

Trajectories of individual symptoms in remitters versus non-remitters with depression.

Sakurai H, Uchida H, Abe T, Nakajima S, Suzuki T, Pollock BG, Sato Y, Mimura M.

J Affect Disord.  2013

Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.

Caravaggio F, Raitsin S, Gerretsen P, Nakajima S, Wilson A, Graff-Guerrero A.

Biol Psychiatry.  2013

Factor structure of the targeted inventory on problems in schizophrenia.

Tanaka S, Nagase T, Suzuki T, Nomura K, Takeuchi H, Nakajima S, Uchida H, Yagi G, Watanabe K, Mimura M.

Clin Psychopharmacol Neurosci.  2013

The potential role of dopamine D₃ receptor neurotransmission in cognition.

Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow T, Le Foll B, Mulsant B, Pollock B, Graff-Guerrero A.

Eur Neuropsychopharmacol.  2013

Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey.

Tani H, Uchida H, Suzuki T, Shibuya Y, Shimanuki H, Watanabe K, Den R, Nishimoto M, Hirano J, Takeuchi H, Nio S, Nakajima S, Kitahata R, Tsuboi T, Tsunoda K, Kikuchi T, Mimura M.

BMC Oral Health.  2012

Patient's trust in their psychiatrist: a cross-sectional survey.

Minamisawa A, Suzuki T, Watanabe K, Imasaka Y, Kimura Y, Takeuchi H, Nakajima S, Kashima H, Uchida H.

Eur Arch Psychiatry Clin Neurosci.  2011

How long to wait before reducing antipsychotic dosage in stabilized patients with schizophrenia? A retrospective chart review.

Takeuchi H, Suzuki T, Uchida H, Kikuchi T, Nakajima S, Manki H, Watanabe K, Kashima H.

J Psychiatr Res.  2011

Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies.

Shinfuku M, Nakajima S, Uchida H, Watanabe K, Kocha H, Kashima H.

Psychiatry Clin Neurosci.  2011

The evolution of antipsychotic switch and polypharmacy in natural practice--a longitudinal perspective.

Tsutsumi C, Uchida H, Suzuki T, Watanabe K, Takeuchi H, Nakajima S, Kimura Y, Tsutsumi Y, Ishii K, Imasaka Y, Kapur S.

Schizophr Res.  2011

Plasma substance P level in patients with schizophrenia: a cross-sectional study.

Ishida T, Uchida H, Suzuki T, Nakajima S, Watanabe K, Kashima H.

Psychiatry Clin Neurosci.  2011

Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M.

Prog Neuropsychopharmacol Biol Psychiatry.  2011

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.

Nakajima S, Suzuki T, Watanabe K, Kashima H, Uchida H.

Prog Neuropsychopharmacol Biol Psychiatry.  2010

Depression severity and effect of antidepressant medications.

Suzuki T, Uchida H, Nakajima S.

JAMA.  2010

Magnitude of rater differences in assessment scales for schizophrenia.

Suzuki T, Takeuchi H, Nakajima S, Nomura K, Uchida H, Yagi G, Watanabe K, Kashima H.

J Clin Psychopharmacol.  2010